Stock Research for JNJ

Featured Broker: Ally Invest

Get the due diligence for another stock.


JNJ Stock Chart & Research Data

The JNJ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JNJ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


JNJ Due diligence Resources & Stock Charts

The JNJ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View JNJ Detailed Price Forecast - CNN Money CNN View JNJ Detailed Summary - Google Finance
Yahoo View JNJ Detailed Summary - Yahoo! Finance Zacks View JNJ Stock Research & Analysis -

Stock Analysis

TradeIdeas View JNJ Trends & Analysis - Trade-Ideas Barrons View JNJ Major Holders - Barrons
NASDAQ View JNJ Call Transcripts - NASDAQ Seeking View JNJ Breaking News & Analysis - Seeking Alpha
Spotlight View JNJ Annual Report - OTC Report View JNJ OTC Short Report -
TradeKing View JNJ Fundamentals - TradeKing Charts View JNJ SEC Filings - Bar Chart
WSJ View Historical Prices for JNJ - The WSJ Morningstar View Performance/Total Return for JNJ - Morningstar
MarketWatch View the Analyst Estimates for JNJ - MarketWatch CNBC View the Earnings History for JNJ - CNBC
StockMarketWatch View the JNJ Earnings - StockMarketWatch MacroAxis View JNJ Buy or Sell Recommendations - MacroAxis
Bullish View the JNJ Bullish Patterns - American Bulls Short Pains View JNJ Short Pain Metrics -

Social Media Mentions

StockTwits View JNJ Stock Mentions - StockTwits PennyStocks View JNJ Stock Mentions - PennyStockTweets
Twitter View JNJ Stock Mentions - Twitter Invest Hub View JNJ Investment Forum News - Investor Hub
Yahoo View JNJ Stock Mentions - Yahoo! Message Board Seeking Alpha View JNJ Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for JNJ - Insider Cow View Insider Transactions for JNJ - Insider Cow
CNBC View JNJ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for JNJ - OTC Markets
Yahoo View Insider Transactions for JNJ - Yahoo! Finance NASDAQ View Institutional Holdings for JNJ - NASDAQ

Stock Charts

FinViz View JNJ Stock Insight & Charts - StockCharts View JNJ Investment Charts -
BarChart View JNJ Stock Overview & Charts - BarChart Trading View View JNJ User Generated Charts - Trading View

Latest Financial News for JNJ

'We're ahead of the pack' in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus
Posted on Thursday September 20, 2018

CNBC's Jim Cramer sits down with Yuval Cohen, the CEO of a company that is creating treatments derived from manmade cannabinoids for rare diseases like cystic fibrosis. Cohen says that his small pharmaceutical company is beating big pharma when it comes to these treatments.

7 Dow Jones Stocks Leading the Push to New Highs
Posted on Thursday September 20, 2018

The Dow Jones Industrial Average finally pushed above its January record high on Thursday, ending a year-long consolidation range that was spurred by worries over higher interest rates, Federal Reserve policy tightening and the fallout from President Trump’s trade war.

Here’s a clear case for owning dividend stocks instead of bonds
Posted on Thursday September 20, 2018

Hank Smith, co-chief investment officer of Haverford Trust, has laid out a clear case for dividend stocks over bonds. Pepsi’s stock had a dividend yield of 3.25% as of the close on Sept. 18, while 10-year U.S. Treasury paper yielded 3.05%.

Analysts Are Overwhelmingly Bullish on Abbott Laboratories
Posted on Thursday September 20, 2018

Abbott Laboratories (ABT) is one of the leading medical technology companies in the world. It offers products across its Medical Devices, Nutrition, Diagnostics, and Established Pharmaceuticals segments, with most of its products having the highest market shares in their respective markets. On July 18, the company released its most recent quarterly results and exceeded analysts’ estimates.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.